RxDoctor Payments Data

Kimberly Riano

Primary Care · Olympia, WANPI 1033133566

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $6,663 of the $7,562 with a category attached, or 88.1%. Organon accounts for 89.5% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2023 at $4,726 and has fallen 74.6% since, to $1,199 in 2024. Among primary care clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,562in general payments, 2019–2025

Across 51 payments — averaging $148.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$7K
  • Astellas Pharma US Inc$97
  • Lilly USA, LLC$75
  • AbbVie$71
  • AstraZeneca$51
  • Dexcom, Inc.$49
  • plus $455 from 17 others

What the payments were for

  • Speaking & faculty fees$6,66388%
  • Travel & lodging$681%
  • Food & beverage$76310%
  • Education$681%

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,562 in reported general payments places this provider in the 90th percentile of 94 primary care providers in Washington.

See all primary care providers in Washington

Other primary care in Olympia

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →